Antibacterial and synergy of a flavanonol rhamnoside with antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA)

Phytomedicine

Volumn 18, Issue 11, 2011, Pages 990-993

  An, J ^a,b   Zuo, G Y ^a   Hao, X Y ^b   Wang, G C ^a   Li, Z S ^c  

^a KUNMING GENERAL HOSPITAL   (China)

^b GUIZHOU MEDICAL UNIVERSITY   (China)

^c PLA   (China)

Author keywords

Anti MRSA activity; Ceftazidime; Levofloxacin; Synergy; Taxifolin 7 O l rhamnopyranoside

Indexed keywords

AMPICILLIN; AROMADENDRIN 7 O ALPHA LEVO RHAMNOPYRANOSIDE; AZITHROMYCIN; CEFTAZIDIME; FLAVONOID; FLAVONOL; LEVOFLOXACIN; PYRANOSIDE; QUERCETIN 7 O ALPHA LEVO RHAMNOPYRANOSIDE; TAXIFOLIN; TAXIFOLIN 7 O ALPHA LEVO RHAMNOPYRANOSIDE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; HYPERICUM; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

AMPICILLIN; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CEFTAZIDIME; DRUG SYNERGISM; FLAVONOLS; GLYCOSIDES; HUMANS; HYPERICUM; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; OFLOXACIN; QUERCETIN; SPUTUM;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;

EID: 80051879036     PISSN: 09447113     EISSN: 1618095X     Source Type: Journal    
DOI: 10.1016/j.phymed.2011.02.013     Document Type: Article

References (23)

1. A.S. Awaad, D.J. Maitland, and G.A. Soliman Hepatoprotective activity of Schouwia thebica web Bioorg. Med. Chem. Lett. 16 2006 4624 4628 (Pubitemid 44094060)
2. S. Chang, D.M. Sievert, J.C. Hageman, M.L. Boulton, F.C. Tenover, F.P. Downes, S. Shah, J.T. Rudrik, G.R. Pupp, W.J. Brown, D. Cardo, and S.K. Fridkin Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene N. Engl. J. Med. 348 2003 1342 1347 (Pubitemid 36384101)
3. J.N. Chin, R.N. Jones, H.S. Sader, P.B. Savage, and M.J. Rybak Potential synergy activity of the novel ceragenin, CAS-13, against clinical isolates of Pseudomonas aeruginosa, including multidrug-resistant P. aeruginosa J. Antimicrob. Chemother. 61 2008 365 370
4. Clinical Laboratory Standards Institute Methods for Determining Bactericidal Activity Antimicrobial Agents. Approved Guidelines. Document M26-A 1999 CLSI (formerly NCCLS) Wayne, PA
5. Clinical Laboratory Standards Institute Performance Standards for Antimicrobial Disk Susceptibility Tests. Approved Standard, 9th ed. Document M2-A9 2006 CLSI Wayne, PA
6. Clinical Laboratory Standards Institute Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, 7th ed. Approved Standard M7-A7 2006 CLSI Wayne, PA
7. Clinical Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing-17th Informational Supplement. Approved Standard M100-S17 2007 CLSI Wayne, PA
8. T.P. Cushnie, and A.J. Lamb Antimicrobial activity of flavonoids Int. J. Antimicrob. Agents 26 2005 343 356 (Pubitemid 41483464)
9. S. Gibbons Anti-staphylococcal plant natural products Nat. Prod. Rep. 21 2004 263 277 (Pubitemid 38527319)
10. S. Gibbons Phytochemicals for bacterial resistance - strengths, weaknesses and opportunities Planta Med. 74 2008 594 602 (Pubitemid 351846775)
11. S. Hemaiswarya, A.K. Kruthiventi, and M. Doble Synergism between natural products and antibiotics against infectious diseases Phytomedicine 15 2008 639 652
12. Z.Q. Hu, W.H. Zhao, N. Asano, Y. Yoda, Y. Hara, and T. Shimamura Epigallocatechin gallate synergistically enhances the activity of carbapenems against methicillin resistant Staphylococcus aureus Antimicrob. Agents Chemother. 46 2002 558 560 (Pubitemid 34087216)
13. K. Ishiguro, S. Nagata, H. Fukumoto, M. Yamaki, S. Takagi, and K. Isoi A flavanonol rhamnoside from Hypericum japonicum Phytochemistry 30 1991 3152 3153
14. M.P. Jevons "Celbenin"-resistant staphylococci Br. Med. J. 124 1961 124 125
15. W.K. Kloos, and T.L. Bannerman Staphylococcus and micrococcus P.R. Murray, E.J. Baron, M.A. Pfaller, Manual of Clinical Microbiology 7th ed. 1999 ASM Press Washington, DC 264 282
16. G.B. Mahady Medicinal plants for the prevention and treatment of bacterial infections Curr. Pharm. Des. 11 2005 2405 2427 (Pubitemid 40872687)
17. M. Matsuo, N. Sasaki, K. Saga, and T. Kaneko Cytotoxicity of flavonoids toward cultured normal human cells Biol. Pharm. Bull. 28 2005 253 259 (Pubitemid 40880004)
18. G. Orhan, A. Bayram, Y. Zer, and I. Balci Synergy tests by E test and chequerboard methods of antimicrobial combinations against Brucella melitensis J. Clin. Microbiol. 43 2005 140 143 (Pubitemid 40096291)
19. P.J. Petersen, P. Labthavikul, C.H. Jones, and P.A. Bradford In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis J. Antimicrob. Chemother. 57 2006 573 576 (Pubitemid 43240214)
20. H. Wagner, and G. Ulrich-Merzenich Synergy research: approaching a new generation of phytopharmaceuticals Phytomedicine 16 2009 97 110
21. K. Zhang, J.A. McClure, S. Elsayed, T. Louie, and J.M. Conly Novel multiplex PCR assay for characterization and concomitant subtyping of staphylococcal cassette chromosome mec types I to V in methicillin-resistant Staphylococcus aureus J. Clin. Microbiol. 43 2005 5026 5033 (Pubitemid 41483999)
22. G.Y. Zuo, F.Y. Meng, X.Y. Hao, Y.L. Zhang, G.C. Wang, and G.L. Xu Antibacterial Alkaloids from Chelidonium majus Linn (Papaveraceae) against clinical isolates of methicillin-resistant Staphylococcus aureus J. Pharm. Pharmaceut. Sci. 11 2008 90 94
23. G.Y. Zuo, G.C. Wang, Y.B. Zhao, G.L. Xu, X.Y. Hao, J. Han, and Q. Zhao Screening of Chinese medicinal plants for inhibition against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) J. Ethnopharmacol. 120 2008 287 290